Table 2. Treatment, Medication Use, and Comorbid Disorders of Remitted and Persistent Patients.
| Remitted patients (N=21) | Persistent patients (N=22) | Test statistic | p-Value | |||
|---|---|---|---|---|---|---|
| Treatment | ||||||
| Total sessions | 9.3±6.7 | 9.5±4.5 | t=−0.15 | 0.88 | ||
| EMDR | N=16 | N=19 | 0.39 | |||
| Total sessions | 5.3±2.5 | 6.6±4.0 | t=−1.12 | 0.24 | ||
| tfCBT | N=5 | N=10 | 0.14 | |||
| Total sessions | 10.6±6.6 | 7.3±5.1 | t=1.08 | 0.30 | ||
| Pre | Post | Pre | Post | p-Value pre | p-Value post | |
| Medication (no.) | 10 | 8 | 8 | 12 | 0.46 | 0.28 |
| SSRI | 4 | 3 | 6 | 11 | 0.52 | 0.01 |
| Benzodiazepine | 6 | 6 | 3 | 2 | 0.23 | 0.10 |
| SARI | 0 | 1 | 2 | 1 | 0.16 | 0.97 |
| Antipsychotics | 0 | 1 | 1 | 3 | 0.32 | 0.32 |
| Nicotine antagonist | 1 | 0 | 0 | 0 | 0.30 | 1.00 |
| β-Blocker | 1 | 0 | 1 | 0 | 0.97 | 1.00 |
| Comorbid disorders (no.) | 12 | 3 | 19 | 10 | 0.03 | 0.03 |
| Mood | 10 | 1 | 14 | 6 | 0.29 | 0.05 |
| Anxiety | 3 | 2 | 11 | 5 | 0.01 | 0.24 |
| Somatic | 1 | 0 | 1 | 1 | 0.97 | 0.32 |
Abbreviations: EMDR, eye-movement desensitization and reprocessing; pre, pretreatment; post, post-treatment; tfCBT, trauma-focused cognitive behavioral therapy.
Numbers for total treatment sessions represent group means±SD.
The p-values for the number of patients (EMDR, tfCBT, medication, and comorbid disorder) are based on χ2 analyses.
The p-value used to indicate significance is p<0.05.